title: Survival in patients with HIV infection and viral hepatitis B or C: a cohort study.
abstract: OBJECTIVE
  To assess survival in patients with HIV and viral hepatitis co-infection.
  
  
  METHODS
  A prospective university clinic cohort of 472 patients with HIV infection who were followed for 8343 patient-months. The outcome measures were the survival from HIV or liver disease assessed by the Kaplan-Meier method. Multivariable analysis using a Cox regression model identified variables associated with mortality.
  
  
  RESULTS
  Patients were divided into four subgroups: HIV/hepatitis B virus (HBV) (n = 72), HIV/hepatitis C virus (HCV) (n = 256), multiple hepatitides (n = 18) and HIV alone (n = 126). One hundred and thirty-four patients (28.4%) died during follow-up. Liver mortality was noted in 55 patients, representing 12% of the cohort and 41% of the total mortality. Survival curves were similar in patients with HIV alone and those with any viral hepatitis co-infection. Liver deaths were more common in patients with multiple hepatitides (28%) HIV/HBV (15%), HIV/HCV co-infection (13%) versus HIV alone (6%). Liver mortality was comparable in HIV/HBV as in HIV/HCV co-infected patients and was not associated with gender, ethnicity, age, or mode of infection. HIV deaths were similar in patients co-infected with viral hepatitis compared with those with HIV alone. In patients with viral hepatitis co-infection, initial CD4 cell count > 200 x 10(6) cells/l and use of highly active antiretroviral therapy (HAART) were associated with significantly reduced liver mortality.
  
  
  CONCLUSIONS
  Patients with HIV and viral hepatitis had greater liver mortality than patients with HIV alone, but had comparable HIV mortality. Co-infection with hepatitis B is associated with hepatic outcomes similar to hepatitis C. Control of immunosuppression with HAART and CD4 counts > 200 x 10(6) cells/l are associated with better hepatic outcomes and should be the first priority in patients with HIV and viral hepatitis.
authors.affiliation: Department of Medicine, University of Southern California School of Medicine, Los Angeles, California, USA. Bonacim@sutterhealth.org
authors.forename: Maurizio
authors.initials: M
authors.lastname: Bonacini
authors.forename: Stan
authors.initials: S
authors.lastname: Louie
authors.forename: Natalie
authors.initials: N
authors.lastname: Bzowej
authors.forename: Amy Rock
authors.initials: AR
authors.lastname: Wohl
mesh_terms: D000328:Adult; D000368:Aged; D002140:California / Q000453:epidemiology; D004812:Epidemiologic Methods; D005260:Female; D015658:HIV Infections / Q000150:complications / Q000401:mortality*; D006509:Hepatitis B / Q000150:complications / Q000401:mortality*; D006526:Hepatitis C / Q000150:complications / Q000401:mortality*; D006801:Humans; D008297:Male; D008875:Middle Aged